AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

VACcination of LIver Transplantation Candidates

Recruitingn/aAges 18 Years - anyAllHospices Civils de Lyon
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Chronic hepatic disease, and especially cirrhosis, are associated to a global dysfunction of the immune system. Liver transplantation represents the only replacement therapy for end-stage liver disease and a curative means of localized hepatocellular carcinoma (HCC) but required immunosuppressive treatment to limit the risk of rejection. Candidates for liver transplantation are at an increased risk for severe infections, some of which can be prevented by vaccination. With regard to vaccine preventable diseases, these patients share the same pitfalls than all immunocompromised individuals: i) a theoretical or proven increased incidence and severity of certain infections warranting specific vaccine recommendations; ii) a decrease in immunogenicity of vaccine; iii) a risk of developing vaccine disease after administration of live attenuated vaccines. It is therefore recommended for all pati

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * age โ‰ฅ 18 years old * patients waiting for liver transplantation referred by hepato-gastroenterology department as part of the pre-transplant evaluation to the infectiology consultation * patient who were informed of the study and did not object to participate Exclusion Criteria: * patient candidate for multi-organ transplant * patient who received immunosuppressive therapy, biotherapy and/ or corticosteroid therapy at a dose greater than 10 mg / day of prednisone equivalent for more than 2 weeks within 3 months before vaccination (6 months of rituximab) * patient who received polyvalent immunoglobulins within the 6 months before the serological evaluation * patient who received systemic anti-cancer chemotherapy for solid tumor or hemopathy within 6 months preceding the start of vaccination * splenectomized patients * asplenic patients for a reason other than liver disease * chronic infection with the human immunodeficiency virus (HIV) * patient with any other hereditary immune deficiency or acquired which could compromise the vaccine response or interpretation of serological results * patient under legal protection measure or unable to consent to the study
๐Ÿ’Š

What it tests

  • Vaccine immunogenicity
๐Ÿ“

Where

1 site
Service des maladies infectieuses et tropicales - Hรดpital de la Croix-Rousse
Lyon, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy